NO20065814L - Thiendopyridinon forbindelser og fremgangsmater for behandling - Google Patents
Thiendopyridinon forbindelser og fremgangsmater for behandlingInfo
- Publication number
- NO20065814L NO20065814L NO20065814A NO20065814A NO20065814L NO 20065814 L NO20065814 L NO 20065814L NO 20065814 A NO20065814 A NO 20065814A NO 20065814 A NO20065814 A NO 20065814A NO 20065814 L NO20065814 L NO 20065814L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- methods
- vomiting
- ischemic stroke
- depression
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4743—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57185204P | 2004-05-17 | 2004-05-17 | |
US10/955,434 US7488736B2 (en) | 2004-05-17 | 2004-09-30 | Thienopyridinone compounds and methods of treatment |
PCT/US2005/017121 WO2005121151A2 (fr) | 2004-05-17 | 2005-05-16 | Composes de thieno-pyridinone et procedes de traitement associes |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065814L true NO20065814L (no) | 2007-02-12 |
Family
ID=35310219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065814A NO20065814L (no) | 2004-05-17 | 2006-12-15 | Thiendopyridinon forbindelser og fremgangsmater for behandling |
Country Status (12)
Country | Link |
---|---|
US (2) | US7488736B2 (fr) |
EP (1) | EP1746994A4 (fr) |
JP (1) | JP4897683B2 (fr) |
KR (1) | KR101216296B1 (fr) |
AU (1) | AU2005252632B2 (fr) |
BR (1) | BRPI0510022A (fr) |
CA (1) | CA2567268C (fr) |
IL (1) | IL178996A0 (fr) |
MA (1) | MA28582B1 (fr) |
NO (1) | NO20065814L (fr) |
RU (1) | RU2006144867A (fr) |
WO (1) | WO2005121151A2 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7612078B2 (en) * | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US20050222175A1 (en) * | 2004-03-31 | 2005-10-06 | Dhanoa Dale S | New piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7488736B2 (en) * | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7576211B2 (en) * | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
US7598265B2 (en) * | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
US7407966B2 (en) * | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
KR20070097590A (ko) | 2005-01-25 | 2007-10-04 | 에픽스 델라웨어, 인코포레이티드 | 치환된 아릴아민 화합물 및 5―ht6 조절제로서의 이의용도 |
US7799316B2 (en) * | 2006-02-14 | 2010-09-21 | Exxonmobil Chemical Patents Inc. | Process for manufacturing MCM-22 family molecular sieves |
WO2010065743A2 (fr) * | 2008-12-03 | 2010-06-10 | Nanotherapeutics, Inc. | Composés bicycliques et leurs procédés de fabrication et d'utilisation |
US9453027B2 (en) | 2009-07-27 | 2016-09-27 | Daljit Singh Dhanoa | Deuterium-enriched pyridinonecarboxamides and derivatives |
US8557994B2 (en) * | 2009-07-27 | 2013-10-15 | Daljit Singh Dhanoa | Deuterium-enriched pyridinonecarboxamides and derivatives |
CN103153959A (zh) | 2010-10-14 | 2013-06-12 | 伊姆纳尔公司 | 作为AhR活化剂的1,2-二氢-4-羟基-2-氧代-喹啉-3-甲酰苯胺类 |
WO2013009830A1 (fr) * | 2011-07-13 | 2013-01-17 | Tempero Pharmaceuticals, Inc. | Méthodes de traitement |
WO2013009810A1 (fr) * | 2011-07-13 | 2013-01-17 | Tempero Pharmaceuticals, Inc. | Méthodes de traitement |
WO2013009827A1 (fr) * | 2011-07-13 | 2013-01-17 | Tempero Pharmaceuticals, Inc. | Méthodes de traitement |
WO2013009812A1 (fr) * | 2011-07-13 | 2013-01-17 | Tempero Pharmaceuticals, Inc | Méthodes de traitement |
WO2021014365A1 (fr) | 2019-07-22 | 2021-01-28 | Lupin Limited | Composés macrocycliques utilisés en tant qu'agonistes sting et procédés et utilisations de ceux-ci |
CN114569566A (zh) * | 2020-12-02 | 2022-06-03 | 四川科瑞德制药股份有限公司 | 一种盐酸米那普仑制剂的制备方法 |
WO2023135508A1 (fr) * | 2022-01-11 | 2023-07-20 | Suven Life Sciences Limited | Composés de pyrrolo[1,2-b]-2-pyridazinone en tant qu'agonistes du récepteur 5-ht4 |
US11725016B1 (en) | 2022-06-02 | 2023-08-15 | Nanopharmaceutics, Inc | Compositions and methods for oral delivery of crystalline PRX-3140 potassium salt |
Family Cites Families (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3069412A (en) | 1958-08-15 | 1962-12-18 | Fmc Corp | N-aminoazetidine and preparation thereof |
CA933923A (en) | 1969-12-19 | 1973-09-18 | Eichenberger Kurt | Process for the manufacture of new thiopyranes |
GB1570494A (en) | 1975-11-28 | 1980-07-02 | Ici Ltd | Thienopyrimidine derivatives and their use as pesticides |
DE2925175A1 (de) | 1979-06-22 | 1981-01-08 | Basf Ag | Verfahren zur herstellung von isatosaeureanhydriden |
IT1203323B (it) | 1987-02-02 | 1989-02-15 | Hoechst Italia Spa | Additivo fotoattivatore per composizioni polimeriche costituito dal sale metallico di una cera ossidata |
US5236917A (en) | 1989-05-04 | 1993-08-17 | Sterling Winthrop Inc. | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
DE4008726A1 (de) | 1990-03-19 | 1991-09-26 | Basf Ag | Thieno(2,3-d)pyrimidinderivate |
US5143919A (en) * | 1990-08-17 | 1992-09-01 | Takeda Chemical Industries, Ltd. | Thienopyridine derivatives and their pharmaceutical use |
JP3086295B2 (ja) * | 1990-08-17 | 2000-09-11 | 武田薬品工業株式会社 | チエノピリジン誘導体、その製造法およびacat阻害剤 |
US5219864A (en) * | 1991-03-12 | 1993-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
US5155115A (en) | 1991-03-12 | 1992-10-13 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
US5227387A (en) | 1991-09-03 | 1993-07-13 | Dowelanco | Quinoline nematicidal method |
DE4138820A1 (de) | 1991-11-26 | 1993-05-27 | Basf Ag | Chinolin-3-carbonsaeureamide, deren herstellung und verwendung |
DE4208254A1 (de) | 1992-03-14 | 1993-09-16 | Hoechst Ag | Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid |
DE4227747A1 (de) | 1992-08-21 | 1994-02-24 | Basf Ag | Heteroaromatisch kondensierte Hydroxypyridoncarbonsäureamide, deren Herstellung und Verwendung |
US5409948A (en) | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
JPH06239858A (ja) | 1993-02-16 | 1994-08-30 | Otsuka Pharmaceut Co Ltd | 末梢血管拡張剤 |
GB9306460D0 (en) | 1993-03-29 | 1993-05-19 | Smithkline Beecham Plc | Novel compounds |
GB9311562D0 (en) * | 1993-06-04 | 1993-07-21 | Fujisawa Pharmaceutical Co | Heterocyclic derivatives |
TW449600B (en) * | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
JP3829879B2 (ja) | 1994-05-18 | 2006-10-04 | 大正製薬株式会社 | キノリンカルボン酸誘導体 |
GB2295387A (en) | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
DE19636769A1 (de) | 1996-09-10 | 1998-03-12 | Basf Ag | 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung |
DE19724980A1 (de) | 1997-06-13 | 1998-12-17 | Basf Ag | 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung |
JPH11130777A (ja) | 1997-08-13 | 1999-05-18 | Takeda Chem Ind Ltd | チエノピリジン誘導体、その中間体およびそれらの製造法 |
ATE404539T1 (de) * | 1997-10-02 | 2008-08-15 | Eisai R&D Man Co Ltd | Kondensierte pyridinderivate |
WO1999043681A1 (fr) * | 1998-02-26 | 1999-09-02 | Neurogen Corporation | Pyridines heteroaryle fondues substituees 4-(4-piperidylmethylamino); ligands du recepteur cerebral gaba |
DE19815026A1 (de) | 1998-04-03 | 1999-10-07 | Hoechst Schering Agrevo Gmbh | Substituierte Piperidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide |
MXPA00011889A (es) * | 1998-06-02 | 2003-04-25 | Osi Pharm Inc | Composiciones de pirrolo (2,3d) piridina y su uso. |
US6232320B1 (en) * | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
EP1173168A2 (fr) | 1999-04-28 | 2002-01-23 | Respiratorius AB | Un compose pour l'utilisation d'un medicament destine au traitement de troubles de contraction bronchique |
SE9902987D0 (sv) | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
JP3868811B2 (ja) | 1999-10-01 | 2007-01-17 | 大日本住友製薬株式会社 | 新規キナゾリン誘導体 |
EP1270568A1 (fr) | 2001-06-19 | 2003-01-02 | Biofrontera Pharmaceuticals AG | 1-Méthyl-4-(3-éthoxy-9H-thioxanthène-ylidène)-pipéridine et son utilasition en tant qu'antagoniste du recepteur 5-HT2B et/ou H1 |
WO2003020728A1 (fr) * | 2001-08-30 | 2003-03-13 | Pharmacia & Upjohn Company | Agents antiviraux a base de 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carbothioamides |
MXPA03000145A (es) * | 2002-01-07 | 2003-07-15 | Pfizer | Compuestos de oxo u oxi-piridina como moduladores de receptores 5-ht4. |
AU2003298514A1 (en) | 2002-05-17 | 2004-05-04 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
US20040138238A1 (en) | 2002-08-08 | 2004-07-15 | Dhanoa Dale S. | Substituted aminopyrimidine compounds as neurokinin antagonists |
AU2003255845A1 (en) | 2002-08-22 | 2004-03-11 | Piramed Limited | Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
WO2004030629A2 (fr) | 2002-10-01 | 2004-04-15 | Predix Pharmaceuticals | Nouveaux antagonistes de la neurokinine et leurs procedes d'utilisation |
US20040097492A1 (en) * | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
US7153858B2 (en) | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
NZ542236A (en) | 2003-03-31 | 2008-05-30 | Predix Pharmaceuticals Holding | New piperidinylamino-thieno[2,3-d]pyrimidine compounds |
US20050222175A1 (en) | 2004-03-31 | 2005-10-06 | Dhanoa Dale S | New piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7612078B2 (en) | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7119205B2 (en) * | 2003-05-16 | 2006-10-10 | Abbott Laboratories | Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
RU2357734C2 (ru) | 2003-07-25 | 2009-06-10 | Ф.Хоффманн-Ля Рош Аг | КОМБИНАЦИЯ АНТАГОНИСТА РЕЦЕПТОРА mGluR2 И ИНГИБИТОРА ФЕРМЕНТА AChE ДЛЯ ЛЕЧЕНИЯ ОСТРЫХ И/ИЛИ ХРОНИЧЕСКИХ НЕВРОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ |
GB0322140D0 (en) | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
US20050137142A1 (en) | 2003-11-03 | 2005-06-23 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
US7488736B2 (en) | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US20060084806A1 (en) | 2004-07-21 | 2006-04-20 | Ramasubramanian Sridharan | Processes for the preparation of imidazo[1,2-a] pyridine derivatives |
US7407966B2 (en) | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7576211B2 (en) | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
US7598265B2 (en) | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
KR20070097590A (ko) | 2005-01-25 | 2007-10-04 | 에픽스 델라웨어, 인코포레이티드 | 치환된 아릴아민 화합물 및 5―ht6 조절제로서의 이의용도 |
US7855193B2 (en) | 2005-11-23 | 2010-12-21 | Epix Pharmaceuticals, Inc. | S1P receptor modulating compounds and use thereof |
AR061637A1 (es) | 2006-06-26 | 2008-09-10 | Epix Delaware Inc | Composiciones y metodos de tratamiento de trastornos del snc |
WO2008045558A2 (fr) | 2006-10-12 | 2008-04-17 | Epix Delaware, Inc. | Composés de benzothiadazine et leur utilisation |
CL2007003305A1 (es) | 2006-11-17 | 2008-07-04 | Epix Delaware Inc | Compuestos analogos de adenosina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermdades tales como fibrosis quistica, otitis media, asma, ulcera peptica, entre otras. |
-
2004
- 2004-09-30 US US10/955,434 patent/US7488736B2/en active Active
-
2005
- 2005-05-16 CA CA2567268A patent/CA2567268C/fr active Active
- 2005-05-16 RU RU2006144867/04A patent/RU2006144867A/ru not_active Application Discontinuation
- 2005-05-16 WO PCT/US2005/017121 patent/WO2005121151A2/fr active Application Filing
- 2005-05-16 EP EP05779361A patent/EP1746994A4/fr not_active Withdrawn
- 2005-05-16 AU AU2005252632A patent/AU2005252632B2/en active Active
- 2005-05-16 JP JP2007527345A patent/JP4897683B2/ja not_active Expired - Fee Related
- 2005-05-16 BR BRPI0510022-4A patent/BRPI0510022A/pt not_active Application Discontinuation
-
2006
- 2006-11-01 IL IL178996A patent/IL178996A0/en unknown
- 2006-11-13 MA MA29451A patent/MA28582B1/fr unknown
- 2006-11-15 KR KR1020067023904A patent/KR101216296B1/ko not_active IP Right Cessation
- 2006-12-15 NO NO20065814A patent/NO20065814L/no not_active Application Discontinuation
-
2008
- 2008-12-24 US US12/343,818 patent/US7982040B2/en active Active - Reinstated
Also Published As
Publication number | Publication date |
---|---|
AU2005252632A1 (en) | 2005-12-22 |
US7982040B2 (en) | 2011-07-19 |
AU2005252632B2 (en) | 2012-03-01 |
MA28582B1 (fr) | 2007-05-02 |
US20090163537A1 (en) | 2009-06-25 |
KR20070047237A (ko) | 2007-05-04 |
JP2007538084A (ja) | 2007-12-27 |
CA2567268C (fr) | 2013-07-09 |
US20050256153A1 (en) | 2005-11-17 |
IL178996A0 (en) | 2007-03-08 |
RU2006144867A (ru) | 2008-06-27 |
US7488736B2 (en) | 2009-02-10 |
BRPI0510022A (pt) | 2007-09-25 |
KR101216296B1 (ko) | 2012-12-28 |
JP4897683B2 (ja) | 2012-03-14 |
EP1746994A4 (fr) | 2008-01-23 |
WO2005121151A3 (fr) | 2006-05-18 |
WO2005121151A2 (fr) | 2005-12-22 |
EP1746994A2 (fr) | 2007-01-31 |
CA2567268A1 (fr) | 2005-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065814L (no) | Thiendopyridinon forbindelser og fremgangsmater for behandling | |
TW200621245A (en) | Thienopyridinone compounds and methods of treatment | |
JP4592077B2 (ja) | 嘔吐、抑鬱、不安および咳の処置のためのニューロキニン−1(nk−1)アンタゴニストとしての1−アミド−4−フェニル−4−ベンジルオキシメチル−ピペリジン誘導体および関連化合物 | |
JP4091648B2 (ja) | 2−(1h−インドリルスルファニル)−ベンジルアミン誘導体 | |
WO2005040135A1 (fr) | Medicament antistress et usage medical correspondant | |
CA2559530C (fr) | Nouveaux derives de benzyl(idene)-lactame | |
JPH07149762A (ja) | ピペリジン類およびピペラジン類 | |
TW200628472A (en) | Piperidinylamino-thieno (2,3-d) pyrimidine compounds | |
JPWO2005047286A1 (ja) | スピロ複素環化合物 | |
ATE402935T1 (de) | Kondensierte heterocyclische verbindungen und deren verwendung als antagonisten des metabotropen rezeptors zur behandlung von gastrointestinalen erkrankungen | |
NO20055029L (no) | Nye piperidinylamino-tieno[2,3-di]pyrimidinforbindelser | |
NO20054005L (no) | Nye arylpiperazinylforbindelser | |
JP2003524571A (ja) | インドール−及び2,3−ジヒドロインドール誘導体、その製造方法及びその使用方法 | |
JP6950534B2 (ja) | テトラヒドロナフタレン誘導体 | |
ATE449092T1 (de) | Indazolcarbonsäureamidderivate als agonisten des 5ht4-rezeptors | |
JP4865710B2 (ja) | 情動障害、疼痛、adhdおよび腹圧性尿失禁の治療に使用するための2−(1h−インドリルスルファニル)−アリールアミン誘導体 | |
Mésangeau et al. | Preparation and pharmacological evaluation of a novel series of 2-(phenylthio) benzo [b] thiophenes as selective MT2 receptor ligands | |
WO2006024955A1 (fr) | Antagonistes des recepteurs d'amine histamine-3 azabicycliques | |
WO2007069671A1 (fr) | Compose heterocyclique bicyclique | |
JP4216072B2 (ja) | ドーパミンd2受容体及びセロトニン再取り込み部位に対する高い親和性を有する8−{4−[3−(5−フルオロー1h−インドール−3−イル)−プロピル]−ピペラジン−1−イル}−2−メチル−4h−ベンゾ[1,4]オキサジン−3−オンメシラート | |
CN1805954A (zh) | 用作血清素再摄取抑制剂的吲哚衍生物 | |
CN1336925A (zh) | 4,5,6和7-吲哚及二氢吲哚衍生物,它们的制备和应用 | |
JP2002510675A (ja) | うつ病治療用のn−アリールオキシエチル−インドリル−アルキルアミン(5−ht1a受容体活性薬) | |
JP6943239B2 (ja) | Kcnq2〜5チャネル活性化剤 | |
UA87845C2 (ru) | Производные тиенопиридинона и способ лечения расстройств нервной системы |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |